The secretion of both soluble C regulators, like FH/FHL-1, and the release of membrane regulators can thus provide additional resistance to ovarian tumours in the AF or at least restrict the activity of the C system within the AF. This evidence concerns the gene FHL1 and ovarian neoplasm.